197 related articles for article (PubMed ID: 35803085)
1. To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection.
Stastna D; Menkyova I; Drahota J; Hrnciarova T; Kubala Havrdova E; Vachova M; Andelova M; Kleinova P; Kovarova I; Krasulova E; Preiningerova JL; Novakova I; Novotna K; Novotna M; Nytrova P; Pavlickova J; Srpova B; Storey K; Ticha V; Tyblova M; Uher T; Vodehnalova K; Horakova D
Mult Scler Relat Disord; 2022 Sep; 65():104014. PubMed ID: 35803085
[TBL] [Abstract][Full Text] [Related]
2. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
[TBL] [Abstract][Full Text] [Related]
3. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience.
Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M
Front Immunol; 2023; 14():1106472. PubMed ID: 36761740
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
[TBL] [Abstract][Full Text] [Related]
5. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
[TBL] [Abstract][Full Text] [Related]
6. Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD.
Dinoto A; Sechi E; Ferrari S; Gajofatto A; Orlandi R; Solla P; Maccabeo A; Maniscalco GT; Andreone V; Sartori A; Manganotti P; Rasia S; Capra R; Mancinelli CR; Mariotto S
Mult Scler Relat Disord; 2022 Feb; 58():103424. PubMed ID: 35216793
[TBL] [Abstract][Full Text] [Related]
7. Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
Paybast S; Emami A; Baghalha F; Naser Moghadasi A
Mult Scler Relat Disord; 2022 Sep; 65():103960. PubMed ID: 35763914
[TBL] [Abstract][Full Text] [Related]
8. Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study.
Lee S; Muccilli A; Schneider R; Selchen D; Krysko KM
Mult Scler; 2023 Apr; 29(4-5):595-605. PubMed ID: 36840605
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD.
Yeo T; Quek AML; Yong KP; Tye JSN; Ratnagopal P; Soon DTL; Tan K
Mult Scler Relat Disord; 2022 Sep; 65():104003. PubMed ID: 35803084
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.
Mirmosayyeb O; Ghaffary EM; Vaheb S; Pourkazemi R; Shaygannejad V
Rev Neurol (Paris); 2023 Apr; 179(4):265-281. PubMed ID: 36658048
[TBL] [Abstract][Full Text] [Related]
11. Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
Motahharynia A; Naghavi S; Shaygannejad V; Adibi I
Mult Scler Relat Disord; 2022 Oct; 66():104035. PubMed ID: 35858498
[TBL] [Abstract][Full Text] [Related]
12. Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
Januel E; De Seze J; Vermersch P; Maillart E; Bourre B; Pique J; Moisset X; Bensa C; Maarouf A; Pelletier J; Vukusic S; Audoin B; Louapre C;
Mult Scler; 2022 Jun; 28(7):1155-1159. PubMed ID: 34931885
[TBL] [Abstract][Full Text] [Related]
13. Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis.
Tong Y; Liu J; Yang T; Kang Y; Wang J; Zhao T; Cheng C; Fan Y
Mult Scler Relat Disord; 2018 Oct; 25():61-65. PubMed ID: 30048918
[TBL] [Abstract][Full Text] [Related]
14. Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
Mealy MA; Cook LJ; Pache F; Velez DL; Borisow N; Becker D; Arango JAJ; Paul F; Levy M
Mult Scler Relat Disord; 2018 Jul; 23():78-82. PubMed ID: 29783157
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccination in people with multiple sclerosis, real-life experience.
Alroughani R; Al-Hashel J; Abokalawa F; AlMojel M; Farouk Ahmed S
Clin Neurol Neurosurg; 2022 Sep; 220():107374. PubMed ID: 35961255
[TBL] [Abstract][Full Text] [Related]
16. Optic Neuritis Following the BNT162b2 mRNA COVID-19 Vaccine in a Patient with Systemic Lupus Erythematosus Uncovering the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Shirah B; Mulla I; Aladdin Y
Ocul Immunol Inflamm; 2023 Aug; 31(6):1213-1215. PubMed ID: 35849732
[TBL] [Abstract][Full Text] [Related]
17. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19.
Fragoso YD; Gomes S; Gonçalves MVM; Mendes Junior E; Oliveira BES; Rocha CF; Santos GACD; Tauil CB; Araujo RV; Peron JPS
Mult Scler Relat Disord; 2022 Jan; 57():103321. PubMed ID: 35158439
[TBL] [Abstract][Full Text] [Related]
18. The impact of COVID-19 on a Southern Chinese cohort with neuromyelitis optica spectrum disorders.
Zhong J; Wu Y; Zhou S; Liu C; Wen Y; Liang M; Li T; Lu T; Lv S; Gong Z; Lao D; Cao X; Tang Y; Huang W
Mult Scler Relat Disord; 2024 Jan; 81():105120. PubMed ID: 37979411
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review.
Nabizadeh F; Ramezannezhad E; Kazemzadeh K; Khalili E; Ghaffary EM; Mirmosayyeb O
J Clin Neurosci; 2022 Oct; 104():118-125. PubMed ID: 36029752
[TBL] [Abstract][Full Text] [Related]
20. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
Fragomeni MO; Bichuetti DB; Oliveira EML
Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
